Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 17.60M | $ 51.30M | $ 9.20M | $ 45.70M | $ 31.40M |
Total Assets | $ 676.70M | $ 542.90M | $ 503.80M | $ 534.50M | $ 527.20M |
Total Debt | $ 82.40M | $ 9.50M | $ 10.90M | $ 35.10M | $ 95.30M |
Net Debt | $ 64.80M | $ -41.80M | $ 1.70M | $ -10.60M | $ 63.90M |
Total Liabilities | $ 153.70M | $ 70.40M | $ 68.10M | $ 75.80M | $ 146.60M |
Stockholders Equity | $ 523.00M | $ 472.50M | $ 435.70M | $ 458.70M | $ 380.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |